首页> 外文期刊>The biochemical journal >Effect of antimicrotubule agents on terminal glycosyltransferases and other enzymes associated with rat liver subcellular fractions
【24h】

Effect of antimicrotubule agents on terminal glycosyltransferases and other enzymes associated with rat liver subcellular fractions

机译:抗微管剂对末端糖基转移酶及其他与大鼠肝亚细胞部分有关的酶的影响

获取原文
获取外文期刊封面目录资料

摘要

pPrevious studies have shown that anti microtubule agents disrupt Golgi complexes in hepatocytes and other cells, causing breakdown or vesiculation of Golgi cisternal membranes. Whether this change in the structure of the Golgi membranes is associated with changes in Golgi membrane function is not known. The present study was initiated to investigate this issue; i.e., to determine whether anti-microtubule agents that cause structural changes in Golgi membranes in vivo would, at the same time, affect characteristic enzyme functions of Golgi membranes. To this end, colchicine was given to young rats in vivo and various hepatic subcellular membranes were subsequently isolated and utilized for enzyme assays. Initially it was shown that colchicine (2.5 mg/kg body wt.) given for 5h significantly decreased the activities of the Golgi membrane associated enzymes galactosyl-, sialyl- and N-acetylglucosaminyl-transferases. More detailed experiments indicated that low doses of colchicine (0.8 mg/kg body wt.), although less effective than higher doses, decreased the activities of the terminal glycosylating enzymes maximally at 5h, with partial and complete recovery at 12 and 24h respectively. Treatment in vivo of rats with vinblastine (20 mg/kg body wt.) for 5h mimicked the action of colchicine. Two microsomal glycosylating enzymes (mannosyl and N acetylglucosaminyl transferases) were unaffected by the treatment with colchicine, as were various hepatic ‘marker’ enzymes such as 5′ nucleotidase, glucose 6 phosphatase and succinate: 2-(p iodophenyl)-3-(p nitrophenyl)-5-phenyltetrazolium reductase (succinate dehydrogenase; EC 1.3.99.1), which were found to be enriched in plasma membrane, endoplasmic-reticulum and mitochondrial-membrane fractions respectively. These results show that anti-microtubule agents specifically suppress the activity of Golgi-associated glycosyltransferases in liver. Although it seems likely that these changes are related to the previously observed structural changes in hepatocyte Golgi complexes after colchicine treatment, to what extent the results are linked to the interaction of colchicine with microtubule protein remains to be clarified./p
机译:>以前的研究表明,抗微管剂会破坏肝细胞和其他细胞中的高尔基复合体,导致高尔基体脑膜破裂或囊泡化。高尔基体膜结构的这种变化是否与高尔基体膜功能的变化有关是否是未知的。本研究旨在调查此问题。即,确定在体内引起高尔基体膜结构改变的抗微管剂是否会同时影响高尔基体膜的特征性酶功能。为此,将秋水仙碱体内给予幼鼠,随后分离出各种肝亚细胞膜并用于酶测定。最初显示秋水仙碱(2.5 mg / kg体重)给予5h会显着降低高尔基体膜相关酶半乳糖基,唾液酸和N-乙酰氨基葡萄糖氨基转移酶的活性。更详细的实验表明,低剂量的秋水仙碱(0.8 mg / kg体重)虽然效果不如高剂量,但在5h时最大程度地降低了末端糖基化酶的活性,分别在12h和24h时部分和完全恢复。用长春碱(20 mg / kg体重)在大鼠体内进行5h的体内处理可模拟秋水仙碱的作用。秋水仙碱处理不影响两种微粒体糖基化酶(甘露糖基和N乙酰氨基葡萄糖氨基转移酶),以及各种肝“标志物”酶(如5'核苷酸酶,葡萄糖6磷酸酶和琥珀酸酯):2-(对碘苯基)-3-(p硝基苯基)-5-苯基四唑鎓还原酶(琥珀酸脱氢酶; EC 1.3.99.1),发现它们分别富含质膜,内质网和线粒体膜部分。这些结果表明抗微管剂特异性抑制肝脏中高尔基体相关的糖基转移酶的活性。尽管这些变化可能与秋水仙碱处理后先前观察到的肝细胞高尔基复合体的结构变化有关,但结果在多大程度上与秋水仙碱与微管蛋白的相互作用有关仍有待阐明。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号